{'fraction_non_alphanumeric': 0.026151930261519303, 'fraction_numerical': 0.007471980074719801, 'mean_word_length': 5.813559322033898, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Abstract PR010: Procalcitonin As An Early Predictor of Systemic Inflammatory Response with Or Without Infection in Patients Undergoing Coronary Artery Bypass Surgery

Background & Objectives: Cardiac surgery using cardiopulmonary bypass (CPB) is associated a non-specific acute systemic inflammatory response (SIRS) [1]. Also, sepsis after cardiac surgery is responsible for significant morbidity and mortality. Early sepsis recognition and intervention improves outcomes. Procalcitonin (PCT) has emerged as a biomarker for bacterial infections because it correlates with the extent and severity of microbial invasion and with outcome [2, 3]. We examined the use of serial samples of procalcitonin for early detection of patients with SIRS with or without infection after coronary artery bypass surgery.